Skip to content
Multiple Sclerosis News Today logo Newsletter
Newsletter
  • About MS
    Multiple sclerosis overview
    • Types of MS
    • Causes and risk factors
    • Symptoms
    • Diagnosis
    • Living with MS
    Treatments options for MS
    • Approved treatments
    • Experimental treatments
    Clinical Trials
    • What are clinical trials?
    • Types of clinical trials
    • How do clinical trials work?
    • Traditional vs. remote vs. hybrid clinical trials
    • FAQs about clinical trials
  • Featured Topics
    Newly diagnosed guide
    • Continuing MS treatment
    • MS and employment
    • Next steps after an MS diagnosis
    • MS caregivers guide
    • MS healthcare team
    • Perspectives on MS diagnosis
    • MS treatment explainer
    • Questions to ask your doctor
    • Guidelines for MS diagnosis
    • Physical activity and quality of life
    • View all
    MS pathways
    • MS and sleep
    • Videos: Worth the talk
    • Managing RRMS
    • Changing MS therapy
    • Mental health and MS
    • MS spasticity stretches
    • MS apps and tools
    • Energy levels and MS
    • MS and eating
    Living strong
    • MS and chronic pain
    • Stress and MS
    • MS and exercise
    • MS safe home tips
    • MS in women
    • Talking to your doctor
    • Recognizing MS symptoms
    • MS and restless leg syndrome
    Resources
    • MS hug
    • MS and heat
    • Cannabis and MS
    • Lesions and MS
    • Myelin's role in MS
    • Epstein-Barr virus and MS
    • Stem cell therapy for MS
    • MS prognosis and life expectancy
    • MS and mental health
    Expert voices
    • Exercise
    • Pain management
    • Cannabis use
    • Diet and nutrition
    • Financial planning
    • Managing fatigue
    • Sleeping well
    • More
  • News
  • Columns
    Authentically Human – Desiree Lama
    Balancing Grit and Grace – Ahna Crum
    Chairborne — Ben Hofmeister
    Delicate Balance – Leigh Anne Nelson
    Rhythms and Routines – Susan Payrovi, MD
    Archived Columns
    • A Life in Letters — Jamie Hughes
    • DISabled to ENabled — Jessie Ace
    • Dive to Fight MS – Mike Parker
    • Fall Down, Get Up Again — John Connor
    • Goldilochs — Stephen De Marzo
    • Patiently Awakened — Teresa Wright-Johnson
    • The MS Wire — Ed Tobias
    • Silver Linings — Jennifer Powell
    In memoriam
    • Through the Looking Glass — Beth Shorthouse-Ullah
  • Forums
  • Video & Podcasts
    Get Tough on Multiple Sclerosis Video Series
    Get Tough on Multiple Sclerosis Podcast
    The Multiple Sclerosis Podcast
  • Advocacy partners
  • What can we help you find today?

October 25, 2021 Columns by Ed Tobias

MS News That Caught My Eye Last Week: AHSCT, Ocrevus, CD20 T-cells, Spasticity App

National MS Society Supports Stem Cell Transplant for Select, Aggressive RRMS Bravo! This statement is welcome after the recommendation of National Multiple Sclerosis Society advisers that autologous hematopoietic stem cell transplant, or AHSCT, could be useful for people younger than 50 and recently diagnosed with MS. Now, how long…

October 20, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – App’s Use Prolongs Gains of Spasticity Rehab Program

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Four…

October 19, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – CD20-positive T-cells May Be Early Drivers of MS

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Certain types of…

October 19, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Problems in Thalamus Linked to Severe Progressive MS

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. In people with progressive multiple sclerosis (MS), neuron loss…

October 19, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Spinal Cord Lesions Predictive of SPMS Conversion in CIS

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Lesions…

October 19, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Nrg-1-treated Immune Cells Can Promote Myelin Repair

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. A…

October 18, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Early Ocrevus Slows MS Better Versus 2-year Delay

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Early use of…

October 18, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Economic Burden of MS in US Exceeded $85B in 2019

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. The total economic…

October 18, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Relapse-free Worsening More Likely in Late-onset MS

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. People…

October 18, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Ublituximab Better Than Aubagio at Reducing Disability

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. The investigational anti-CD20…

October 15, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Quitting Smoking May Help Slow MS Progression

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Multiple…

October 15, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Sativex Eases MS Patients’ Spasticity, Spasms in Trials

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. Sativex…

October 15, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Lower Relapse Rates Seen With Tysabri Than Ocrevus

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference. People with …

October 15, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Stem Cell Transplant May Better Treat SPMS Than DMTs

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference.

October 14, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Brain Lesions Help Predict Long-term Disability

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the…

October 14, 2021 News by Marta Figueiredo, PhD

#ECTRIMS2021 – Childhood Sexual, Emotional Abuse Increases MS Risk

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference.

October 13, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Ponvory Effective in Early MS in OPTIMUM Trial

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the conference.

October 13, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 — Rituximab as First RRMS Therapy Outperforms Others

Editor’s note: The Multiple Sclerosis News Today team is providing in-depth coverage of the virtual 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 13–15. Go here to see the latest stories from the…

October 6, 2021 News by Marisa Wexler, MS

#ECTRIMS2021 – Trial Analyses Support Evobrutinib for Relapsing MS

Treatment with evobrutinib, an experimental therapy for relapsing forms of multiple sclerosis (MS), reduced the size of inflammation-associated brain lesions in a Phase 2 clinical trial, data show. The oral medication was also found to be generally safe and well tolerated, according to an analysis of trial data in…

September 30, 2021 News by Steve Bryson, PhD

#ECTRIMS2021 – ATA188 Benefits in SPMS, PPMS Hint at Remyelination

An investigational immunotherapy, ATA188 showed it could reverse disability and improve exercise capacity in people with progressive forms of multiple sclerosis (MS), Atara Biotherapeutics, its developer, reported in an update on a Phase 1 trial and its long-term extension study. EMBOLD trial findings based on MRI brain imaging…

Recent Posts

  • MRI finding may reduce need for invasive spinal tap to diagnose MS
  • 50+ events planned May 25 for nationwide MS Walks in Canada
  • How multiple sclerosis can complicate casual conversation


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.